Welcome to October Insights. Inside this edition: ORISE Fellowships, Biden Cancer Summit, and more!
October Insights
New ORISE Fellowship Opportunities

The Food and Drug Administration and the National Institute of Environmental Health Sciences National Toxicology Program (NTP) have partnered to offer Oak Ridge Institute for Science and Education (ORISE) fellowship positions focused on cardiovascular drug safety screening. The initiative’s goal is to develop a novel framework to model cardiovascular hazards and understand the underlying pathways. The fellowship position will be located at the NTP in Research Triangle Park, North Carolina, USA.

Read more or apply online here .
Biden Cancer Summit
On September 21, HESI’s Executive Director, Syril Pettit, attended the Biden Cancer Summit on behalf of the HESI THRIVE Initiative. THRIVE is one of only fifty programs nationwide recognized by the Biden Cancer Initiative toward their goal of rapidly advancing cancer cures and improving patient outcomes. HESI THRIVE , now in its second funding cycle, is a grant program that provides seed funding for research to better understand and reduce cancer treatment-related adverse effects that can impact patient quality of life. THRIVE helps to enhance the lifetime benefit of existing therapies by better predicting, preventing, or reducing unintended adverse effects associated with therapy.
Special thanks to HESI THRIVE’s 2018 supporters: HESI, Amgen, and the National Patient Advocate Foundation. If you’d like to join as a supporter for this amazing program – please contact us at research@hesithrive.org .

Grant proposals are due 19 October 2018, so act now! The Advisory Board will invite a limited number of initial submissions to submit a full proposal, with the next grant award period to launch in early 2019.

Read the full press release here , and visit the THRIVE website here .
Emerging Issues 2019: Call for Proposals
HESI is seeking your suggestions for new scientific projects (human or environmental health) for consideration as an emerging issue in 2019. Proposals will be reviewed in early 2019, and one or more will be selected to form a new scientific collaborative program within HESI. Although this is not a grant, the selected program will receive support from HESI for scientific program design, coordination, and staffing.

Learn more about the HESI Emerging Issues Process on our website or download the proposal form here . The deadline to submit proposals is 14 December 2018 . Don’t miss out!
New Staff

Please join us in welcoming HESI’s newest staff member, Maddy Barnes! Maddy is our Member Relations & Communications Manager and comes to us with her BA from the University of Michigan. Before joining HESI, Maddy worked as the Marketing & Communications Manager for Make-A-Wish ® Mid-Atlantic and has past experience working in healthcare communications and public relations.
Recent Publication

Blinova K, Dang Q, Millard D, Smith G, Pierson J, Liang G, Brock M, Lu HR, Kraushaar U, Zeng H, Shi H, Zhang X, Sawada K, Osada T, Kanda Y, Sekino Y, Pang L, Feaster TK, Kettenhofen R, Stockbridge N, Strauss DG, and Gintant G (2018) International multisite study of human induced pluripotent stem cell derived cardiomyocytes for drug proarrhythmic potential assessment. Cell Reports. 24(13):3582–3592. Read More
From the Executive Director
What an incredible honor and thrill to attend the inaugural Biden Cancer Summit last month. Not surprisingly for an event hosted by a former Vice-President - it was filled with the nation’s leading cancer researchers and clinicians, directors of patient advocacy organizations, tech-company CEOs, and therapy developers. But it was not their presence that left the greatest impact on me. Rather, it was the voices of the patients, the parents, and the families whose lives have been forever impacted by cancer. These voices resonate not only because they are honest and raw – but because we have all heard or spoken with that voice in our own lives as well.  Initiatives like the Biden Cancer Summit shine a light on the breadth of challenges and opportunities ahead – and the millions of people seeking this better future. Programs like HESI THRIVE and innovative research partnerships within HESI’s Cardiac and Immunotoxicology Committees are also critical steps forward. To learn more about how to join or support us in these efforts, please contact me at research@hesithrive.org .
Syril D. Pettit
HESI Executive Director
Health and Environmental Sciences Institute (HESI)
740 Fifteenth Street, NW
6th Floor
Washington, DC 20005-1743
| 202.659.3306 | 202.659.3859| HESI@hesiglobal.org| www.hesiglobal.org